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ESTRO: A REGIONAL ONCOLOGY SOCIETY ON THE MOVE
G. Heeren
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ESTRO, founded in 1982, has stimulated
and coached the emergence of radiation
oncology as a separate in Europe. Its growth was
organical and driven by the pioneer sprint, vision
and energy of its "founding fathers". In 1997, 15
years later, the Society counts more than 4 000
members and represents the vast majority of
European proffesionals active in the field of
radiation oncology. At this historical moment
ESTRO is doing some deep soul searching to
find out whether its present structure, goals and
activities are still adequate to face up to the
challenges of the 21 st century, to streamline an
interactive communications with its members and
provide the guidance and services rightfully
expected from it in a region rapidly converging
towards a new European space.
In a "conclave" - type meeting in a former
monastery in Italy a group of yong members were
brought together to put under scrutiny 8 areas
considered to be of major importance to the
Society, to assess the present status and explore
new paths, horizonts and boundaries. The Board
joined them later to listen to their criticism and
capture their audacious dream and projects. Will
the Society be able to produce the power of
imagination required to set free, harness and tap
this powerful stream of new energy? Will it be
able to generate the resources to deliver on the
vast range of expectations of a new generation of
members who, it is hoped, have served as an
unprejudiced and candid mouthpeace of its
membership at large.
PROBLEMS IN CARRYING OUT THE PROSPECTIVE CLINICAL TRIAL OF III rd PHASE
Andrzej Hliniak
Radiotherapy, Cancer Institute, Warsaw, Poland
In 1994 the project multicenter studies has been elaborated.
Objectives
Implementation of QA standards in
radiotherapy of laryngeal carcinoma irradiated in
eight radiotherapy centers (multicenter study) in
Poland.
The elaboration of study design and
practical implementation of multicenter
prospective studies (clinical trial).
Rationale
The QA standards are at present most
important subject of activities in radiotherapy both
in practice and in research. The improvement in
QA can result in improvement of the outcomes of
treatment and decrease the risk of postirradiation
damage.
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The retrospective analyses of several
materials of head and neck cancers treated with
irradiation indicated the detrimental effect of
prolongation of overall-treatment-time.
The numerical values of this effect presented in
the literature are often in disagreement with
clinical every-day experience. The elucidation of
this problem in prospective studies (clinical trial)
can be of cognitive and practical value.
It is the first attempt in organizing clinical
trial on such a scale in Polish radiotherapy. The
participating centers give the radiotherapy
services to the population of about 20 min. people.
The problems in collecting data to hold
out the standards in documentation, in follow-up
and benefis observed in the mid-course of this
study will be discussed.
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